glp 1 liver disease GLP-1_receptor_som_behandling_af_steatotisk_leversygdom GLP-1 Fatty Liver MASH Approval:
Description
Article in the comments #GLP1 #FoodTrends #ConsumerBehavior #CulturalListening #Innovation #Ozempic #TrendForecasting #FMCG #CPGMarketing #FutureOfFood | 12 comments on LinkedIn
FDA approves Novo Nordisks first oral GLP-1 pill Wegovy for obesity, offering an injection-free option and improving long-term treatment adherence.
The Latin America Glucagon-like Peptide-1 (GLP-1) Agonists Market worth USD 2.91 billion in 2026 is growing at a CAGR of 8.24% to reach USD 4.33 billion by 2031
The Haldiram's and ITC Foods of the world have time to pivot
Stopping GLP-1 therapy triggers predictable metabolic shifts within weeks
